Trial Profile
The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Cardiovascular disorders; Diabetes mellitus
- Focus Pharmacodynamics
- 30 Apr 2020 Status changed from active, no longer recruiting to completed.
- 15 Sep 2019 Results (n=18) published in the Journal of Clinical Endocrinology and Metabolism.
- 17 Jul 2019 Planned primary completion date changed from 1 Jul 2019 to 31 Dec 2019.